Past News

Blood metabolites associated with coffee consumption may affect kidney disease risk

November 4, 2021

Researchers have identified several metabolites in the blood whose levels are altered by coffee consumption. Levels of 3 of these coffee-related metabolites were significantly associated with individuals' risk of developing chronic kidney disease.

Blood metabolites associated with coffee consumption may affect kidney disease risk

New insights into how the infant microbiome impacts early childhood behavior in boys and girls

November 4, 2021

A new study has found a direct and sex-specific association between the composition of infant microbiome and early childhood behavioral health.

New insights into how the infant microbiome impacts early childhood behavior in boys and girls

For women, greater exposure to estrogen in life may protect brain regions that are vulnerable to Alzheimer’s

November 3, 2021

The drop in estrogen levels that occurs with menopause brings declines in the volumes of 'gray matter,' the cellular matter of the brain, in key brain regions that are also affected in Alzheimer's disease. But a new study suggests that greater cumulative exposure to estrogen in life, for example from having had more children or from having taken menopause hormone therapy, may counter this brain-shrinking effect.

For women, greater exposure to estrogen in life may protect brain regions that are vulnerable to Alzheimer’s

Can eating alone be bad for your heart?

November 3, 2021

As women age, their risk of cardiovascular disease (CVD) exceeds men's largely because of decreased levels of estrogen that regulate vascular function. As a result, much research is focused on various risk factors. A new study suggests that eating alone may contribute to an increased risk of heart disease in older women.

Can eating alone be bad for your heart?

Researchers identify molecule that blocks immune cells from entering and killing breast tumors

November 3, 2021

Researchers have identified a key molecule in certain kinds of breast cancers that prevent immune cells from entering tumors and killing the cancer cells inside. This research could pave the way toward a new treatment for certain kinds of aggressive breast cancer.

Researchers identify molecule that blocks immune cells from entering and killing breast tumors

Artificial intelligence to detect colorectal cancer

November 2, 2021

A researcher found that artificial intelligence can accurately detect and diagnose colorectal cancer from tissue scans as well or better than pathologists, according to a new study.

Artificial intelligence to detect colorectal cancer

Chemo helps breast cancer cells get their ‘foot in the door’ to the lungs

November 2, 2021

A new study adds to the evidence that chemotherapy enhances cancer's spread beyond the primary tumor, showing how one chemo drug allows breast cancer cells to squeeze through and attach to blood vessel linings in the lungs.

Chemo helps breast cancer cells get their ‘foot in the door’ to the lungs

Men experience more emotional pain during breakups

November 2, 2021

The stereotype of men being less emotionally invested in relationships than women may not be accurate, say psychologists. A new study of online relationship support finds that men tend to experience emotional pain more than women when their relationship takes a turn for the worse.

Men experience more emotional pain during breakups

Startup developing device to prevent epilepsy-related death receives funding

November 1, 2021

Neurava, a startup located in West Lafayette, Indiana, announced Monday (Nov. 1) that it has received more than $650,000 in seed funding led by Elevate Ventures with participation from Purdue Foundry, First Leaf Capital, UCB Biopharma, iO Life Ventures and angel investors.

Startup developing device to prevent epilepsy-related death receives funding

New test to diagnose aggressive childhood brain tumors

November 1, 2021

Researchers have developed a new test to more easily diagnose medulloblastoma, the most common malignant childhood brain tumor. The test -- which can distinguish between extremely high-risk medulloblastoma cases that need radiation therapy from those that are lower-risk and do not need radiation -- could help pave the way for personalized treatment options for children suffering from the disease. It relies on an antibody-based technique called immunohistochemistry which is widely available in clinical laboratories around the world.

New test to diagnose aggressive childhood brain tumors